Bill Text: TX HB27 | 2013 | 83rd Legislature 1st Special Session | Introduced


Bill Title: Relating to the research, collection, and use of adult stem cells.

Spectrum: Partisan Bill (Republican 1-0)

Status: (Introduced - Dead) 2013-06-03 - Filed [HB27 Detail]

Download: Texas-2013-HB27-Introduced.html
  83S10050 SCL-D
 
  By: Zedler H.B. No. 27
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the research, collection, and use of adult stem cells.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Subtitle H, Title 3, Education Code, is amended
  by adding Chapter 156 to read as follows:
  CHAPTER 156. ADULT STEM CELL RESEARCH PROGRAM
         Sec. 156.001.  DEFINITIONS. In this chapter:
               (1)  "Adult stem cell" means an undifferentiated cell
  that is:
                     (A)  found in differentiated tissue; and
                     (B)  able to renew itself and differentiate to
  yield all or nearly all of the specialized cell types of the tissue
  from which the cell originated.
               (2)  "Biorepository" means a facility for the storage
  of stem cells for future use.
               (3)  "Consortium" means the Texas Adult Stem Cell
  Research Consortium.
               (4)  "Current good manufacturing practice" has the
  meaning assigned by the United States Food and Drug Administration.
               (5)  "Institution of higher education" means an
  institution of higher education as defined by Section 61.003 or a
  private college or university that receives state funds.
               (6)  "Program" means the adult stem cell research
  program established under this chapter.
               (7)  "Research board" means the Texas Adult Stem Cell
  Research Board.
         Sec. 156.002.  COMPOSITION OF RESEARCH BOARD.  (a)  The Texas
  Adult Stem Cell Research Board is composed of seven members
  appointed as follows:
               (1)  one member of the Texas Higher Education
  Coordinating Board, appointed by the governor;
               (2)  two members who are interested persons, appointed
  by the governor;
               (3)  two members who are interested persons, appointed
  by the lieutenant governor; and
               (4)  two members who are interested persons, appointed
  by the speaker of the house of representatives.
         (b)  The governor shall designate as the presiding officer of
  the research board a board member appointed under Subsection (a)(1)
  or (2). The presiding officer serves in that capacity at the will
  of the governor.
         (c)  The governor shall designate at least one member
  appointed under Subsection (a)(1) or (2) as a stem cell expert, and
  the speaker of the house of representatives shall designate at
  least one member appointed under Subsection (a)(4) as a stem cell
  advocate.
         (d)  The members of the research board serve staggered
  six-year terms. If a vacancy occurs on the board, the appropriate
  appointing authority shall appoint, in the same manner as the
  original appointment, another person to serve for the remainder of
  the unexpired term.
         Sec. 156.003.  CONFLICT OF INTEREST.  (a)  In this section,
  "Texas trade association" means a cooperative and voluntarily
  joined association of business or professional competitors in this
  state designed to assist its members and its industry or profession
  in dealing with mutual business or professional problems and in
  promoting their common interest.
         (b)  A person may not be a member of the research board if:
               (1)  the person is an officer, employee, or paid
  consultant of a Texas trade association in the field of medicine; or
               (2)  the person's spouse is an officer, manager, or paid
  consultant of a Texas trade association in the field of medicine.
         (c)  A person may not be a member of the research board if the
  person is required to register as a lobbyist under Chapter 305,
  Government Code, because of the person's activities for
  compensation on behalf of a profession related to the operation of
  the research board.
         Sec. 156.004.  COMPOSITION OF CONSORTIUM.  (a)  The research
  board shall establish the Texas Adult Stem Cell Research
  Consortium.
         (b)  The consortium is composed of participating
  institutions of higher education and businesses that:
               (1)  accept public money for adult stem cell research;
  or
               (2)  otherwise agree to participate in the consortium.
         Sec. 156.005.  ADMINISTRATION OF PROGRAM; GUIDELINES AND
  PROCEDURES. (a) The research board shall administer the program
  to:
               (1)  from state money appropriated to the research
  board, make grants, investments, or loans to consortium members
  for:
                     (A)  adult stem cell research activities and
  projects, including:
                           (i)  pre-clinical trials and studies;
                           (ii)  treatment protocol development;
                           (iii)  state or federal regulatory
  submissions, including investigational new drug applications
  submitted to and approvals from the United States Food and Drug
  Administration;
                           (iv)  clinical trials conducted in
  coordination with contract research organizations and data safety
  monitoring boards;
                           (v)  intellectual property development; and
                           (vi)  pathways and processes to
  commercialization and to address the collection, development,
  current good manufacturing practice production, biorepository
  storage, characterization, and use of adult stem cells;
                     (B)  the development of facilities to be used
  solely for adult stem cell research projects, biorepository
  storage, and current good manufacturing practice for adult stem
  cell manufacturing and related projects; and
                     (C)  the commercialization of products or
  technology involving adult stem cell research and treatments;
               (2)  support consortium members in all stages of the
  process of developing safe and effective treatments and cures based
  on adult stem cell research, beginning with initial laboratory
  research through current good manufacturing practice and
  successful clinical trials that are:
                     (A)  registered with the United States Food and
  Drug Administration; and
                     (B)  approved by an institutional review board
  that reviews human subjects research protocols under United States
  Department of Health and Human Services guidelines;
               (3)  establish appropriate regulatory standards and
  oversight bodies for:
                     (A)  adult stem cell research conducted by
  consortium members; and
                     (B)  the development of facilities for consortium
  members conducting adult stem cell research, performing
  biorepository storage, and conforming to current good
  manufacturing practice; and
               (4)  assist consortium members in applying for grants,
  investments, or loans under the program.
         (b)  The research board shall develop research priorities,
  guidelines, and procedures for providing grants, investments, and
  loans for specific research projects conducted by consortium
  members.  The priorities, guidelines, and procedures must require
  the grants, investments, and loans to be made on a competitive,
  peer-review basis.
         Sec. 156.006.  FUNDING.  The program may be funded by gifts,
  grants, investments, and donations described by Section 156.007 and
  by money appropriated by the state.
         Sec. 156.007.  GIFTS, GRANTS, AND DONATIONS. The consortium
  shall solicit, and the research board may accept on behalf of the
  consortium, a gift, grant, investment, or donation made from any
  public or private source for the purpose of promoting adult stem
  cell research or commercialization.
         Sec. 156.008.  BIENNIAL REPORT. Not later than September 1
  of each even-numbered year, the research board shall submit a
  report of the research board's activities and recommendations to
  the Texas Higher Education Coordinating Board and to the governor,
  the lieutenant governor, the speaker of the house of
  representatives, and the presiding officer of each legislative
  standing committee or subcommittee with jurisdiction over higher
  education.
         SECTION 2.  Section 162.001, Health and Safety Code, is
  amended by adding Subdivision (4) to read as follows:
               (4)  "Adult stem cell" means an undifferentiated cell
  that is:
                     (A)  found in differentiated tissue; and
                     (B)  able to renew itself and differentiate to
  yield all or nearly all of the specialized cell types of the tissue
  from which the cell originated.
         SECTION 3.  Chapter 162, Health and Safety Code, is amended
  by adding Section 162.020 to read as follows:
         Sec. 162.020.  ADULT STEM CELL COLLECTION. Blood obtained
  by a blood bank may be used for the collection of adult stem cells if
  the donor consents in writing to that use.
         SECTION 4.  Section 241.003, Health and Safety Code, is
  amended by amending Subdivision (1) and adding Subdivision (1-a) to
  read as follows:
               (1)  "Adult stem cell" has the meaning assigned by
  Section 162.001.
               (1-a)  "Advanced practice nurse" means a registered
  nurse recognized as an advanced practice nurse by the Texas Board of
  Nursing.
         SECTION 5.  Subchapter A, Chapter 241, Health and Safety
  Code, is amended by adding Section 241.010 to read as follows:
         Sec. 241.010.  USE OF ADULT STEM CELLS. A hospital may use
  adult stem cells in a procedure if:
               (1)  the stem cells meet current good manufacturing
  practice standards of quality and safety set by the United States
  Food and Drug Administration;
               (2)  a physician providing services at the hospital
  determines that the use of adult stem cells in the procedure is
  appropriate;
               (3)  applicable state and federal regulations are
  followed; and
               (4)  the patient consents in writing to the use.
         SECTION 6.  (a)  As soon as practicable after the effective
  date of this Act, the governor, lieutenant governor, and speaker of
  the house of representatives shall appoint members to the Texas
  Adult Stem Cell Research Board, as required by Section 156.002,
  Education Code, as added by this Act, as follows:
               (1)  the governor shall appoint one member to a term
  expiring February 1, 2015, one member to a term expiring February 1,
  2017, and one member to a term expiring February 1, 2019;
               (2)  the lieutenant governor shall appoint one member
  to a term expiring February 1, 2017, and one member to a term
  expiring February 1, 2019; and
               (3)  the speaker of the house of representatives shall
  appoint one member to a term expiring February 1, 2017, and one
  member to a term expiring February 1, 2019.
         (b)  Not later than September 1, 2014, the Texas Adult Stem
  Cell Research Board shall submit the first report of the board's
  activities and recommendations as required by Chapter 156,
  Education Code, as added by this Act.
         (c)  Notwithstanding Section 156.005(a)(1), Education Code,
  as added by this Act, the Texas Adult Stem Cell Research Board may
  not make a grant, investment, or loan under that section until
  September 1, 2015.
         (d)  Notwithstanding Section 156.006, Education Code, as
  added by this Act, the Texas Adult Stem Cell Research Board may not
  receive a legislative appropriation for the 2013-2014 or 2014-2015
  state fiscal biennium.
         (e)  A gift, grant, investment, or donation received by the
  Texas Adult Stem Cell Research Board before September 1, 2015, may
  be spent only for administrative expenditures, board meetings, and
  planning expenses.
         SECTION 7.  This Act takes effect on the 91st day after the
  last day of the legislative session.
feedback